← Back to Search

3D Perfusion Ultrasound for Liver Cancer

N/A
Waitlist Available
Led By Daniel T. Chang
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-treatment), 0-7 days post treatment, 2-4 months post treatment.
Awards & highlights
No Placebo-Only Group

Summary

This trial will use 3D ultrasound to study how well it can help plan radiation treatment for liver tumors, predict how well the treatment will work, and monitor how the tumor responds to treatment.

Eligible Conditions
  • Liver Cancer
  • Hepatocellular Carcinoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-treatment), 0-7 days post treatment, 2-4 months post treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-treatment), 0-7 days post treatment, 2-4 months post treatment. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Changes in Blood Perfusion (Blood Volume)
Changes in Blood Perfusion (Mean Flow Velocity)
Changes in Blood Perfusion (Relative Blood Flow)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 3D Perfusion UltrasoundExperimental Treatment2 Interventions
undergo 3D ultrasound perfusion imaging with perflutren
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
perflutren lipid microspheres
2007
N/A
~20
3D ultrasound
2007
N/A
~150

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,471 Previous Clinical Trials
17,501,987 Total Patients Enrolled
9 Trials studying Liver Cancer
997 Patients Enrolled for Liver Cancer
Daniel T. ChangPrincipal InvestigatorStanford University
~1 spots leftby Nov 2025